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The oral mucosal pellicle is a layer of absorbed salivary proteins, including secretory IgA
(SIgA), bound onto the surface of oral epithelial cells and is a useful model for all mucosal
surfaces. The mechanism by which SIgA concentrates on mucosal surfaces is examined
here using a tissue culture model with real saliva. Salivary mucins may initiate the formation
of the mucosal pellicle through interactions with membrane-bound mucins on cells. Further
protein interactions with mucins may then trigger binding of other pellicle proteins. HT29
colon cell lines, which when treated with methotrexate (HT29-MTX) produce a gel-forming
mucin, were used to determine the importance of these mucin-mucin interactions. Binding
of SIgA to cells was then compared using whole mouth saliva, parotid (mucin-free) saliva
and a source of purified SIgA. Greatest SIgA binding occurred whenWMS was incubated
with HT29-MTX expressing mucus. Since salivary MUC5B was only able to bind to cells
which produced mucus and purified SIgA showed little binding to the same cells we con-
clude that most SIgA binding to mucosal cells occurs because SIgA forms complexes with
salivary mucins which then bind to cells expressing membrane-bound mucins. This work
highlights the importance of mucin interactions in the development of the mucosal pellicle.
Introduction
The mucus layer is essential for protection, molecular transport and lubrication on soft tissues
and linings of most of the essential organs. Typically in airways and gastrointestinal tract the
mucosal film is formed primarily by mucins, while in other linings like that in the oral cavity
the mucosal film (salivary pellicle) also contains globular proteins and proline-rich proteins.
Among these globular proteins secretory IgA (SIgA) plays an important role in topical immune
response of the adsorbed proteinaceous film. While mucins spontaneously assemble on muco-
sal surfaces in vivo, this behaviour has never yet been fully replicated in vitro using purified
mucins. The inability to replicate the mucosal layer stems from two key factors. Firstly, purifi-
cation of proteins leads to the loss of their tertiary conformation, even if mucin preparations
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are made taking extra care to preserve its gel properties. Secondly, the substrates for in-vitro
measurements are usually inorganic (or plastic) materials that are significantly dissimilar from
the native surface of the cell or connective tissue of the linings. Thus, it has been shown that
MUC5B and MUC7 are strongly retained on the buccal cell surfaces, with minimal retention of
other salivary proteins [1]. This is in contrast with hydrophobised silicon substrates and hy-
droxyapatite, where proteins such as statherin and proline-rich proteins (PRPs) are thought to
initiate pellicle formation and can be found in abundance within the adsorbed film [2, 3].
In this work we adopted an approach that that tackles both issues associated with studying
mucus deposition in vitro. Firstly we utilised saliva as a mucin source, since saliva is the only
mucosal fluid that has ability to self-assemble onto the surface from the bulk solution. Physio-
logically, saliva is synthesised away from the epithelium and assembles only upon its excretion
from the ducts, where the pellicle forms within minutes of exposure to the oral cavity [4]. This
approach ensures that possible effects associated with swelling of mucus gels when extruded
from the specialised cells (e.g. goblet cells in the GI) do not influence our results. The use of sa-
liva has its complications associated with multiple components such as amylase, SIgA, carbonic
anhydrase VI (CAVI) and cystatin S [5]. Secondly we used cell culture as the test substrate. The
HT29 and HT29-MTX cell lines are extremely useful as they provide mucus-depleted or
mucus-rich substrates that otherwise are extremely similar if not identical. A similar cell line
for oral epithelia does not exist but we believe the mechanisms are universal since the major
components (SIgA, mucins etc.,) are common to all mucosal surfaces.
Previous studies of mucin binding to synthetic surfaces suggested hydrophobic interactions
are a dominant force that drives mucin adsorption [3, 6–8], with some additional factors relat-
ed to charges interactions. However, it was also noticed that the adsorption process may rely
on other proteins for crosslinking. This was evident for several proteins including PRPs and
salivary mucins, particularly MUC5B (unpublished data). MUC5B was only able to bind from
UWMS, but not SMSL, and even then in minimal amounts. This could indicate different possi-
ble binding interactions: structural changes due to source of the MUC5B [9, 10] altering its
binding properties or because parotid saliva (PS) proteins were also required for the integration
of salivary MUC5B. For example, acidic PRPs may be involved in TGM crosslinking [2, 11] or
in protein complexation [12].
It is possible that mucin adherence and retention may be aided by attachment to MUC1, a
membrane bound mucin present on the buccal cell surface, through receptor like actions [13,
14]. Other mucin-like glycoproteins, such as gp230, have been identified as being bound to the
mucosa [15], which may also provide an attachment point for mucins. The non-glycosylated
regions of mucins have been shown, on hydrophobic surfaces, to contribute in the creation of
an anchoring layer on the surface whist the glycosylated region protrudes creating viscoelastic
properties [16]. This would be essential for contributing to the lubricious effect [8].
MUC7 may further aid in the pellicle formation by forming complexes with SIgA and lacto-
ferrin, which may improve their incorporation into the pellicle layer [17, 18]. IgA is a key factor
in the innate immune protection [19]. The secretory component attached to IgA (SIgA com-
plex) could also aid in its incorporation into the mucosal pellicle and could protect against pro-
teolytic activity [20].
The aim of this study was to better understand the development of the mucosal pellicle and
specifically the role of mucins, both bound and free, in the absorption of SIgA to the mucosa.
HT29 cells were selected as a model epithelial layer as they can be induced (by methotrexate)
to secrete and form a layer of bound mucus containing a gel forming mucin MUC5AC [21].
SIgA binding was studied from UWMS, PS and SIgA alone to understand whether or not sali-
vary (free) mucins are important for SIgA incorporation.
Mucin-Mucin Interactions in Pellicle Development
PLOS ONE | DOI:10.1371/journal.pone.0119677 March 20, 2015 2 / 13
employed GY. However, this does not alter the
authors’ adherence to PLOS ONE policies on sharing
data and materials. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Materials and Methods
Cell culture
HT29 and HT29-MTX cell lines (Institut für Pharmazeutische Technologie und Biopharmazie,
Marburg, Germany) were cultured in Dulbecco’s modified eagles medium (DMEM) containing
4500 mg/L glucose with 10% fetal bovine serum and 1% penicillin-streptomycin (Sigma-Al-
drich, Dorset, UK). Cells were seeded into 6-well plates at 1:10 concentration in each well from
75 cm2 flask split when approximately 90% confluent. Cells where grown to 3 time points, day
4 (100% confluence), day 8 and day 16 for experimental procedures. At day 8 HT29-MTX cells
have started to produce mucus containing MUC5AC [21], which can be seen visually, and at
day 16 they have a comparatively thick layer of this mucus.
Confocal microscopy
Confocal microscopy on live cells was used to confirm the presence of mucus on cell layers. Im-
ages were taken using Leica Confocal imaging software, using FITC and TRITC fluorescence at
emissions spectra 488 and 568 respectively. After a control image was taken, 10 μl of melamine
formaldehyde particles (0.5 μm diameter) were added which are useful in showing the top
layer of mucus by reflection and 10 μl of TRITC 4 (100 mg/ml) was added to visualise
cell membranes.
Saliva collection and cell incubation
Unstimulated whole mouth saliva (UWMS) was collected from one female volunteer, on the
morning of each experiment, at least 1 hour after consumption of any food or drink. Parotid
saliva (PS) was collected using sweet stimulation whilst using a Lashley cup attached onto the
inside of the cheek, covering Stenson’s duct from the parotid gland. Informed written consent
was obtained for the volunteer to donate saliva following ethical review of the project by the
Brent NRES NHS committee (11/LO/1121). SIgA purified from human colostrum (Sigma,
Dorset, UK) was prepared at a concentration of 50 μg/ml in serum free media. SIgA was later
prepared at 25 μg/ml and 150 μg/ml corresponding to IgA levels in saliva. 1 ml UWMS, PS and
SIgA was then added to cells in triplicate for 20 minute or 1 hour incubation at 37°C, after
washing cells in PBS. Saliva or media was then removed, and kept and frozen at −20°C, cells
were washed in 0.5 ml PBS and homogenised in 0.5 ml of RIPA buffer (Pierce, Thermo Scien-
tific, Rockford, Illinois, USA) according to manufacturer’s instructions.
Protein concentration determination
BCA assay kit (Thermo Scientific) was used to measure total protein in all cell homogenates ac-
cording to manufacturer’s instructions. This ensured equal loading of all cell samples for
SDS-PAGE, western blotting and IgA enzyme-linked immunosorbent assay (ELISA).
IgA binding on all cell and saliva samples were measured using an ELISA, as previously de-
scribed [22]. Rabbit anti-human IgA 1:1000 (Dako, Ely, UK) in carbonate buffer was used to
coat the ELISA plates overnight. Three washes in phosphate buffered saline with 1% Tween
(PBS-T) were completed. Samples were serially diluted down the plate in duplicate alongside
the standard and incubated at 37°C for 1 hour, followed by 3 more PBS-T washes. Detecting
antibody rabbit anti-human IgA HRP 1:10000 was used for 1 hour (Dako) followed by 3 final
PBS-T washes. Substrate was then added consisting of 20 ml sodium acetate, with 3 μl of H2O2
and 500 μl of 3,3’, 5, 5’ tetramethylbenzidine (3 mg/ml in dimethyl sulfoxide). The reaction was
stopped with 2 M sulphuric acid and absorbance was read at 450 nm using a microplate reader
(BioRad, Hemel Hempstead, UK).
Mucin-Mucin Interactions in Pellicle Development
PLOS ONE | DOI:10.1371/journal.pone.0119677 March 20, 2015 3 / 13
SDS-PAGE
SDS-PAGE was completed on cell homogenates. Equal protein amounts of samples were
added to LDS sample buffer (1:4) (Invitrogen, Paisley, UK) and DTT reducing buffer (1:10)
(Invitrogen), with water to make up volumes and heated at 100°C for 3 minutes. 15 μl of each
sample was applied to each lane on a 4–12% Bis-Tris gel (Invitrogen). Electrophoresis was car-
ried out in MES-SDS running buffer (Invitrogen) according to manufacturer’s instructions.
Lanes of buccal cell homogenates and TR146 (oral carcinoma cell line) were run as control
comparisons to proteins expected.
Immunoblotting
After completion of protein separation within the gel, western blotting was completed accord-
ing to manufacturer’s instructions and used to transfer proteins onto a nitrocellulose mem-
brane. Immunoblotting was used to examine specific proteins of interest including: statherin
(1:2000), as described previously [23]), cystatin S (1:2000, R and D Systems, Abingdon, UK),
MUC7 (1:100) and MUC5B (1:100) (EU Consortium, gifts of Prof. Dallas Swallow, University
College London, UK, as described previously [24]). Membranes were blocked in either TBS
with 1% Tween (TTBS) pH 7.6 or TTBS with 2% milk powder (Marvel) added. Membranes
were probed with primary antibodies at room temperature for 1 hour (overnight for mucin de-
tection), washed in TTBS for 15 minutes and then followed incubation with the required sec-
ondary antibody. A final 15 minute wash in TTBS was completed and then the membrane was
incubated with a chemiluminescent substrate, western C (Bio-Rad Laboratories Ltd, Hemel




Fig. 1 shows CSLM Z-stack cross-sections of the HT29 and HT29-MTX cells at day 4, 8 and 16.
The presence of mucus layer was highlighted using reflective MF particles that sat on top of the
mucus layer and appeared as bright spots. At day 4 both HT29 and HT29-MTX cells show that
MF particles (bright spots) are directly adjacent to the cell plasma membrane surface highlight-
ed by TRITC (which stains the cell membranes). This demonstrates very low mucus produc-
tion and absence of continuous mucus layer that covers cells. At day 8 and 16 the HT29-MTX
cells show the development of a thicker mucus layer that displays continuous coverage. The
thickness is somewhat heterogeneous but with no obvious gaps. By contrast, the HT29 cells at
day 8 and 16 show very limited mucus production that (when observable) was patchy and thin-
ner compared to HT29-MTX.
The presence of the mucus layer was further confirmed by gel electrophoresis and western
blotting (Fig. 2). Coomassie with PAS staining of cell homogenates revealed the appearance of
a high molecular weight glycoprotein band in the MTX cells with time. The blots suggested this
band was mostly MUC5AC mucins. It was also evident (although no direct quantification was
conducted) that day 16 showed more mucin staining compared to day 8, which is in line with
confocal microscopy data.
IgA binding to cell layers from saliva
Following a 1 hour incubation of UWMS with both cell lines the amount of IgA bound to the
cells was much greater in the presence of the MUC5AC on the HT29-MTX cells at day 8 and
day 16, as seen in Fig. 3. At day 16 IgA bound to the HT29-MTX cells was over 8x the amount
Mucin-Mucin Interactions in Pellicle Development
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bound to the HT29 cells (p<0.01). This was significantly more than bound to the HT29-MTX
cells at day 4 where there was no MUC5AC mucus development (p<0.05). With a 20 minute
incubation with UWMS, at both day 8 and day 16 there was significantly more IgA binding
onto the HT29-MTX cells (P<0.05 and P<0.01), in comparison to the HT29 cells without the
mucus layer (data not shown).
IgA binding from PS also appeared to show an increase in IgA binding onto the
HT29-MTX cells (Fig. 4); however a one-way ANOVA suggested there was no significant dif-
ference between groups, which is likely to be due to variations of IgA binding to HT29-MTX.
IgA binding from IgA alone compared to IgA in UWMS
When a similar concentration of purified SIgA in media was incubated with the HT29 and
HT29-MTX cells for 20 minute and compared to UWMS there was significantly less binding
compared to the purified SIgA alone (Fig. 5). At day 16, after a 20 minute incubation there was
significantly more IgA binding to the HT29-MTX cells from the UWMS (p<0.01). As before
there was significantly more IgA binding from UWMS to the HT29-MTX cells, compared with
Fig 1. HT29 cell layers at day 4, 8 and 16 and HT29-MTX cells at days 4, 8 and 16, with melamine formaldehyde particles and TRITC 4 added, shows
mucus layer on the HT29-MTX only and high lights cell membranes. HT29 cells at day 8 and 16 don’t show any mucus production like the day 4 time
point. Arrows are described by labels alongside them, with double-ended arrows highlighting cell and mucus thickness.
doi:10.1371/journal.pone.0119677.g001
Fig 2. SDS-PAGE gel and wsetern blots of cell homogenates. Panel A shows a gel stained with CBB and PAS of control cells where no saliva or IgA was
bound. H indicates HT29 cells with the number indicating the time point, M indicates the HT29-MTX cells. Other lanes include the molecular weight standard,
UWMS (W), PS (P), buccal cell homogenate (B) and TR146 cells (T). Boxes highlight mucus band of the MUC5AC. Panel B shows blots of the same
samples, probing for MUC5AC and a cell loading control β-actin.
doi:10.1371/journal.pone.0119677.g002
Mucin-Mucin Interactions in Pellicle Development
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IgA from UWMS binding to the HT29 cells, where MUC5AC was absent from the surface
(P<0.001).
When the same experiment was completed with PS, although there appeared to be increased
binding from PS to HT29-MTX cells at day 16, this result was not statistically significant.
Fig 3. Concentration of IgA bound to equal protein levels of HT29 and HT29-MTX cell lines from UWMS at days 4, 8 and 16. Significantly more IgA is
bound to HT29-MTX cells compared to HT29 cells at day 16 and also significantly more compared to the same cell line at day 4, where *P<0.05 Day 16
HT29-MTX compared to day 4 HT29-MTX, **P<0.01 day 16 HT29-MTX compared to Day 16 HT29.
doi:10.1371/journal.pone.0119677.g003
Fig 4. Concentration of IgA bound to equal protein levels of HT29 and HT29-MTX cell lines from PS at days 4, 8 and 16. There does appear to be an
increase in IgA binding as the MUC5AC later increases on the HT29-MTX cells but this increase is not significant.
doi:10.1371/journal.pone.0119677.g004
Mucin-Mucin Interactions in Pellicle Development
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Binding of salivary mucins to cell layers
Fig. 6 shows MUC5B binding from UWMS to HT29 and HT29-MTX cells. Salivary MUC5B is
one of the two main salivary mucins and it only showed binding to HT29-MTX cells, mostly at
day 16 in the presence of the thick mucus layer on the cells, seen in Fig. 3. The other salivary
mucin MUC7 showed no binding to either cell lines.
Binding of other salivary proteins to cell layers
Fig. 7 shows cystatin S binding fromWMS to HT29 and HT29-MTX cells. Cystatin S was
found to bind preferentially to HT29 MTX cells, although by contrast with MUC5B mucin it
also binds although to a lesser degree to the HT29 cells. This becomes evident at day 16 where
blots showed cystatin S bands for homogenates of both cell lines. Statherin immunoblotting
data (not shown) showed no evidence of binding to any cells.
Discussion
Mucin binding in the pellicle
The results from this work strongly show the importance of a mucin layer in the development
and build-up of a mucosal pellicle. Previously [25] MUC5B was demonstrated to be strongly
retained on buccal cells thereby showing its crucial role in pellicle formation on soft oral tis-
sues. Although our previous paper [3] concluded that hydrophobic interactions do drive
mucin adsorption, the cell surfaces present an altogether different case. We show that MUC5B
Fig 5. IgA Binding to HT29 and HT29-MTX cells frommatched control IgA alone andWMS over 20 minute incubation period. Significantly more IgA
bound to HT29-MTX cells fromWMS then from IgA, *P<0.01. Significantly more IgA also bound to HT29-MTX then to HT29-MTX cells from IgA alone,
*P<0.001.
doi:10.1371/journal.pone.0119677.g005
Mucin-Mucin Interactions in Pellicle Development
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deposition is minimal (not detectable by gel electrophoresis and immunoblotting) on the
HT29 cells that have no mucus production. The absence of a mucus layer on HT29 cells has
been reported previously, and attributed to the fact that the HT29 line contains less than 0.2%
of mucus compared to mucus producing goblet cells [26]. It is also known that HT29 cells have
suppressed expression of membrane bound MUC1 mucins [27], which otherwise covers nearly
all mammalian cells including the oral buccal cells that were tested as being attractive for
MUC5B deposition [28]. It is therefore concluded that presence of mucins on the surface of the
cells is a key for the formation and further build-up of the mucus layer. The deposited amount
correlates with mucin production on the surfaces, as evident from the dependence of mucin
and IgA binding on the day in culture. Thus, at day 16 where there was a thick mucus layer of
MUC5AC [29] the MUC5B was observed at highest levels, which highlights the importance of
mucin-mucin interactions in the development of a protective pellicle [30].
IgA deposition onto cell surfaces from different salivas as well as control IgA solutions also
indicated a requirement for mucin-mucin interactions. Time dependent and concentration de-
pendent trends were observed that characterise mucin-assisted IgA binding to the HT29-MTX
cells. In Fig. 5 it is clearly shown that adsorption of IgA from control solutions (without mu-
cins) was not statistically different from its deposition on HT29 cells. The deposited amounts
were also of the same order as those detected on the HT29 cells following adsorption from the
whole saliva samples, suggesting that the level of binding at 1–2 μg/ml marks the level for un-
specific binding to the cell surfaces. Only in the case when mucins were present both in solu-
tion (as in whole saliva) and on the cell surface (HT29-MTX), were the necessary conditions
Fig 6. MUC5Bwestern blot of cell homogenates. Lanes 1–3 are cell homogenates where cells were
incubated with saliva, C = control (no saliva incubation).
doi:10.1371/journal.pone.0119677.g006
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created for enhanced deposition of IgA to levels of 4.55 μg/ml. The importance of mucins in so-
lution is also evident from data on parotid saliva that lacks mucins. Although there is a trend of
increasing IgA deposition with continued culture (and hence with the amount of the surface
mucins) this change was not statistically significant due to large variations. The absolute values
of deposited IgA are also lower for PS compared with the whole mouth saliva.
In the case of whole mouth saliva, there is a clear concentration dependence (as evident
from the time course trend) which allows the deposition of soluble mucins to be attributed to
the level of mucus production by the cells. Finally we see that other proteins such as cystatin S
that also forms heterotypic complexes with mucins show a similar trend. At the same time
statherin was not typically prominent in the pellicle in contrast to those formed on hydroxyap-
atite surface and air-saliva interfaces [31].
One surprising result was the lack of MUC7 binding, in particular to the HT29-MTX cell or
when strong IgA adherence was observed. As described earlier in the paper, MUC7 is known
Fig 7. Cystatin S western blot of cell homogenates. Lanes 1–3 are cell homogenates where cells were
incubated with saliva, C = control. The centre lane in Day 4 contains a molecular weight standard, whilst day
8 and 16 haveWMS added.
doi:10.1371/journal.pone.0119677.g007
Mucin-Mucin Interactions in Pellicle Development
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to form complexes with IgA [17] and is also thought to be a strongly bound protein integral to
the oral mucosal pellicle [1]. Its lack of binding possibly indicates a lack of interaction with the
mucins expressed on the cell lines used in this work. The surface mucins in this cell line are
mostly MUC5AC whereas oral epithelial cells tend to express MUC1 and little MUC5AC.
These new insights into mucin binding to mucosal surfaces provide an important step in
understanding mucosal pellicle formation as well as help to guide future work to understand
pathological conditions such as xerostomia.
Supporting Information
S1 Data. Supporting information—Data Analysis. Excel spread sheets containing raw data
for the paper entitled ‘SIgA binding to mucosal surfaces is mediated by mucin-mucin interac-
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